External validation of the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer colorectal (CR29) module: Monocentric study

Table 2 Quality of life scores according to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and Quality of Life Questionnaire-CR29 structure and reliability

Scaling/single-item name	n	Item No.	Mean	SD	Floor	Ceiling	Range	ICC
EORTC QLQ-CR29
All patients	221
Urinary frequency		31.32	39.89	33.46	26.2	10.9	0-100	0.961
Blood & mucus in stool		38.39	24.73	29.02	43.4	4.1	0-100	0.969
(F) Body image		45-47	77.82	24.83	1.8	38	0-100	0.950
Defecation/stoma problems		49–54	-	-	-	-	-
Urinary incontinence		33	20.96	32.22	64.7	7.2	0-100	0.982
Dysuria		34	20.66	31.30	63.3	6.8	0-100	0.950
Abdominal pain		35	30.61	34.12	48	8.6	0-100	0.922
Buttock pain		36	27.14	34.62	55.7	9	0-100	0.921
Bloated feeling		37	28.80	33.77	50.2	8.6	0-100	0.945
Dry mouth		40	24.58	34.14	60.2	8.6	0-100	0.979
Hair loss		41	16.44	29.57	71.5	5.9	0-100	0.968
Trouble with taste		42	20.51	32.89	67.0	8.1	0-100	0.975
(F) Anxiety		43	64.67	37.60	16.7	43.4	0-100	0.951
(F) Weight		44	75.56	32.66	8.1	56.6	0-100	0.960
Patients with stoma	50
Flatulence		49s	41.49	33.00	28.6	10.2	0-100	0.908
Leakage		50 s	42.17	36.49	32.7	16.3	0-100	0.889
Sore skin around stoma		51s	42.85	38.49	34.5	20.4	0-100	0.965
Bags change		52.53 s	18.36	22.62	49	2	0-83	0.969
Embarrassed		54s	45.56	43.09	41.8	29.1	0-100	0.956
Stoma care pb		55s	40.08	41.47	46.8	21.5	0-100	0.912
Stoma pb		49-54s	37.41	20.18	4.1	4.1	0-100	0.999
Patients without stoma	172
Flatulence		49	30.62	37.01	52.9	12.8	0-100	0.980
Faecal incontinence		50	26.16	37.38	61.6	14.0	0-100	0.970
Sore skin around anus		51	20.34	31.72	64.5	7.6	0-100	0.979
Stool frequency		52.53	29.65	32.33	38.4	7.6	0-100	0.977
Embarrassment		54	31.20	38.51	54.7	15.1	0-100	0.975
Defecation pb		49-54	28.79	25.84	16.1	0.7	0-100	0.969
Male	123
Sexual functioning		56	42.85	37.81	33	20.5	0-100	0.928
Impotence		57	38.18	38.79	40.9	20	0-100	0.966
Female	98
Sexual functioning		58	67.06	36.76	11.9	48.8	0-100	0.933
Dyspareunia		59	26.58	35.75	58.3	10.7	0-100	0.985
C30	221
Physical function		1 - 5	73.64	23.85	0.9	23.9	0-100	-
Role function		6.7	62.92	37.00	13.3	39.0	0-100	-
Emotional function		21-24	67.24	30.77	4.1	30.7	0-100	-
Cognitive function		20. 25	83.94	23.45	0.5	58.3	0-100	-
Social function		26 . 27	79.58	28.93	3.7	57.3	0-100	-
Fatigue		10.12.18	30.98	29.17	27.1	2.8	0-100	-
Nausea and vomiting		14.15	7.79	17.16	78.0	0.5	0-83	-
Pain		9.19	24.31	29.72	46.8	3.7	0-100	-
Dyspnoea		8	21.10	30.59	62.4	4.6	0-100	-
Insomnia		11	27.67	35.25	56.4	9.2	0-100	-
Appetite loss		13	20.48	30.99	63.3	6.4	0-100	-
Constipation		16	27.52	33.97	53.8	1.4	0-100	-
Diarrhea		17	27.67	34.67	53.2	10.6	0-100	-
Financial difficulties		28	51.22	40.61	30.7	30.7	0-100	-

EORTC: European Organization for Research and Treatment of Cancer; QLQ: Quality of Life Questionnaire.